EBV Treatment with Zephyr® Valves
Managing exacerbations can meaningfully reduce symptoms and future risk in patients with severe COPD/emphysema. A single-center, multi-year, retrospective study reveals a 32% […]
Pulmonx Partners with APAPP
The Association of Pulmonary Advanced Practice Providers (APAPP) and Pulmonx Corporation are excited to announce a new partnership focused on providing APP’s […]
November is COPD Awareness Month
November is National COPD Awareness Month, and the Association of Pulmonary Advanced Practice Providers (APAPP) is committed to empowering both patients and […]